HC Wainwright & Co. Maintains Buy on Incyte, Raises Price Target to $152

HC Wainwright & Co. analyst Mitchell S. Kapoor has maintained a Buy rating on Incyte (NASDAQ: INCY) and increased the price target from $150 to $152.